130 related articles for article (PubMed ID: 22652152)
21. Polygenic risk scores: An overview from bench to bedside for personalised medicine.
Cross B; Turner R; Pirmohamed M
Front Genet; 2022; 13():1000667. PubMed ID: 36437929
[TBL] [Abstract][Full Text] [Related]
22. Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.
Shi Z; Zhan J; Wei J; Ladson-Gary S; Wang CH; Hulick PJ; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; ; Koelsch BL; Xu J
Eur Urol Open Sci; 2022 Nov; 45():23-30. PubMed ID: 36353656
[TBL] [Abstract][Full Text] [Related]
23. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.
Xu J; Resurreccion WK; Shi Z; Wei J; Wang CH; Zheng SL; Hulick PJ; Ross AE; Pavlovich CP; Helfand BT; Isaacs WB
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):422-430. PubMed ID: 35347252
[TBL] [Abstract][Full Text] [Related]
24. Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine.
Meehan J; Gray M; Martínez-Pérez C; Kay C; McLaren D; Turnbull AK
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357131
[TBL] [Abstract][Full Text] [Related]
25. Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Xu J; Isaacs WB; Mamawala M; Shi Z; Landis P; Petkewicz J; Wei J; Wang CH; Resurreccion WK; Na R; Bhanji Y; Novakovic K; Walsh PC; Zheng SL; Helfand BT; Pavlovich CP
Prostate; 2021 Jul; 81(10):703-709. PubMed ID: 33956350
[TBL] [Abstract][Full Text] [Related]
26. Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice.
Gaylis F; Bree KK; Dato P; Andriole GL; Kane CJ; Kader AK
Rev Urol; 2020; 22(4):152-158. PubMed ID: 33927572
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
[TBL] [Abstract][Full Text] [Related]
28. Genetic predisposition to prostate cancer: an update.
Ni Raghallaigh H; Eeles R
Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men.
Oh JJ; Kim E; Woo E; Song SH; Kim JK; Lee H; Lee S; Hong SK; Byun SS
Front Oncol; 2020; 10():583625. PubMed ID: 33194723
[TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphisms based genetic risk score in the prediction of pancreatic cancer risk.
Wang XY; Chen HT; Na R; Jiang DK; Lin XL; Yang F; Jin C; Fu DL; Xu JF
World J Gastroenterol; 2020 Jun; 26(22):3076-3086. PubMed ID: 32587449
[TBL] [Abstract][Full Text] [Related]
31. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
32. Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Shi Z; Yu H; Wu Y; Lin X; Bao Q; Jia H; Perschon C; Duggan D; Helfand BT; Zheng SL; Xu J
Cancer Med; 2019 Jun; 8(6):3196-3205. PubMed ID: 30968590
[TBL] [Abstract][Full Text] [Related]
33. Current progress and questions in germline genetics of prostate cancer.
Isaacs WB; Xu J
Asian J Urol; 2019 Jan; 6(1):3-9. PubMed ID: 30775244
[TBL] [Abstract][Full Text] [Related]
34. Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Wang Q; Gregg JR; Gu J; Ye Y; Chang DW; Davis JW; Thompson TC; Kim J; Logothetis CJ; Wu X
Oncoimmunology; 2019; 8(1):e1483303. PubMed ID: 30546938
[TBL] [Abstract][Full Text] [Related]
35. Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.
Helfand BT; Chen H; Fantus RJ; Conran CA; Brendler CB; Zheng SL; Walsh PC; Isaacs WB; Xu J
Prostate; 2018 Jun; ():. PubMed ID: 29923209
[TBL] [Abstract][Full Text] [Related]
36. Men with a susceptibility to prostate cancer and the role of genetic based screening.
Eeles R; Ni Raghallaigh H
Transl Androl Urol; 2018 Feb; 7(1):61-69. PubMed ID: 29594021
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer screening-when to start and how to screen?
Kohestani K; Chilov M; Carlsson SV
Transl Androl Urol; 2018 Feb; 7(1):34-45. PubMed ID: 29594018
[TBL] [Abstract][Full Text] [Related]
38. Development of risk prediction models for glioma based on genome-wide association study findings and comprehensive evaluation of predictive performances.
Zhao Y; Chen G; Yu H; Hu L; Bian Y; Yun D; Chen J; Mao Y; Chen H; Lu D
Oncotarget; 2018 Feb; 9(9):8311-8325. PubMed ID: 29492197
[TBL] [Abstract][Full Text] [Related]
39. Validation of the novel susceptibility loci for prostate cancer in a Chinese population.
Wu Y; Chen H; Ji Y; Na R; Mo Z; Ye D; Wang M; Qi J; Lin X; Ding Q; Xu J; Zheng SL; Sun Y; Meng W
Oncol Lett; 2018 Feb; 15(2):2567-2573. PubMed ID: 29434975
[TBL] [Abstract][Full Text] [Related]
40. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Grönberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum KU; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM;
BMJ; 2018 Jan; 360():j5757. PubMed ID: 29321194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
